The rising prevalence of overweight and obesity among adults in Malaysia is a growing concern, with statistics revealing that ...

The Allurion swallowable intragastric balloon offers a safe, effective and minimally invasive method of losing weight.

Allurion Technologies (ALUR) aims to end obesity through innovation. Its flagship Allurion Program features a swallowable, procedure-free intragastric balloon designed to aid weight loss. Coupled with ...

Allurion, while battling declining revenues, is targeting the loss in muscle mass seen in patients on GLP-1RA therapy.

Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, Gujarat, India Department of Pharmacology and Toxicology, College of ...

Allurion also disclosed intentions for a clinical trial investigating the combo of GLP-1 agonist therapieslike Novo Nordisk's Ozempic and Eli Lilly's Mounjaroalong with its gastric balloon weight-loss ...

Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, ...

The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world's first and only swallowable, procedure-less TM gastric balloon for weight loss, the Allurion ...

Allurion (NYSE: ALUR) surged 83% premarket after revealing a clinical study combining its gastric balloon product with GLP-1 drugs, showing muscle mass maintenance. Stardust Power (NASDAQ ...

Allurion also disclosed intentions for a clinical trial investigating the combo of GLP-1 agonist therapieslike Novo Nordisk's Ozempic and Eli Lilly's Mounjaroalong with its gastric balloon weight ...

Allurion emphasized earlier studies demonstrating that their non-invasive gastric balloon and Virtual Care Suite software helps patients lose notable weight while either retaining or even building ...